Sign Out
Treatment of acromegaly when the circulating levels of growth hormone (GH) and of IGF-1 remain abnormal after surgery and/or radiotherapy or for whom surgery and/or radiotherapy is not an option.
Treatment of the clinical symptoms associated with acromegaly. Treatment of clinical symptoms associated with carcinoid tumours.
Treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumours (GEP-NETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease (see Pharmacology: Pharmacodynamics under Actions).
